Abstract

Induction of tumor immunity by gp96 secreted from engineered tumor cells

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression
Daniel Meraviglia-Crivelli ... Fernando Pastor
Molecular Therapy—Nucleic Acids | VOL. 29
Daniel Meraviglia-Crivelli, et. al.Daniel Meraviglia-Crivelli ... Fernando Pastor
20 Jul 2022
Enhanced autoimmunity associated with induction of tumor immunity in thyroiditis-susceptible mice.
Suresh Kari ... Bruce E Elliott
Thyroid | VOL. 23
Suresh Kari, et. al.Suresh Kari ... Bruce E Elliott
11 Sep 2013
Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
Alexey Berezhnoy ... Dawn Seales
Molecular Therapy—Nucleic Acids | VOL. 1
Alexey Berezhnoy, et. al.Alexey Berezhnoy ... Dawn Seales
01 Jan 2012
Induction of antitumor immunity using bone marrow-generated dendritic cells.
A Porgador ... E Gilboa
Journal of Immunology | VOL. 156
A Porgador, et. al.A Porgador ... E Gilboa
15 Apr 1996
View more papers

More From: Lung cancer (Amsterdam, Netherlands)

Paper Title
Journal
Date
Author
Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation
Lorenzo Belluomini ... Michele Milella
Lung cancer (Amsterdam, Netherlands) | VOL. -
Lorenzo Belluomini, et. al.Lorenzo Belluomini ... Michele Milella
01 Aug 2024
Befotertinib for patients with pretreated EGFR T790M mutated locally advanced or metastatic NSCLC: Final overall survival results from a phase 2 trial
Shun Lu ... Zhilin Shen
Lung cancer (Amsterdam, Netherlands) | VOL. 195
Shun Lu, et. al.Shun Lu ... Zhilin Shen
27 Jul 2024
Trajectory of PD-L1 expression in a patient underwent neoadjuvant chemo-immunotherapy for resectable NSCLC
Filippo Tommaso Gallina ... Jonathan Spicer
Lung cancer (Amsterdam, Netherlands) | VOL. 194
Filippo Tommaso Gallina, et. al.Filippo Tommaso Gallina ... Jonathan Spicer
26 Jul 2024
Treatment patterns and outcomes in KRASG12C‐positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort study
Samir H Barghout ... Stephanie Snow
Lung cancer (Amsterdam, Netherlands) | VOL. 194
Samir H Barghout, et. al.Samir H Barghout ... Stephanie Snow
25 Jul 2024
View more papers